Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFV/LNG IVR vs TFV IVR in Women in Western Kenya
NCT03762382Phase 2Unknown
- Sponsor
- CONRAD
- Start
- Dec 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir, avatrombopag in human immunodeficiency virus infection (HIV), contraception, sponsored by CONRAD. Status: unknown.
02
Drugs
tenofoviravatrombopag
03
Conditions
human immunodeficiency virus infection (HIV)contraception
Beyond the preview
Go deeper on NCT03762382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762382.